ArticleFrontiers in pharmacology2023

The IDI1/SREBP2 axis drives intrahepatic cholestasis and is a treatment target of San-Huang-Cai-Zhu formula identified by sequencing and experiments.

Junbin Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.